Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: J Neuropsychiatry Clin Neurosci. 2016 Jan 21;28(3):211–216. doi: 10.1176/appi.neuropsych.15090221

Table 1.

Sample Characteristics

N=214 Parkinson Patients
151 Males (70.6%); 63 Females (29.4%) Total Intact Cognition MCI
N=113 N=101
Mean (SD) Mean (SD) Mean (SD)
Percent Caucasian 95.8 98.2 93.1
Age in years 64.3 (9.5) 63.7 (9.5) 65.1 (9.5)
Years of Education 14.9 (2.9) 15.0 (2.8) 14.9 (3.0)
Years with Symptoms 10.0 (5.8) 9.1 (4.6) 10.9 (6.6)
UPDRS Motor Score, on medication 26.1 (10.8) 23.0 (9.5) 29.3 (9.6)
Percent Tremor Predominant 80.8 80.5 81.2
Levodopa Equivalency Dose 829.1 (564.3) 816.4 (590.0) 843.3 (536.7)
Percent on Antidepressant Medication 38.6 37.8 39.6
Percent on Anti-anxiety Medication 19.7 21.6 17.5
Dementia Rating Scale-Total 137.25 (4.9) 139.3 (3.4) 135.0 (5.2)
Beck Depression Scale-II 9.4 (6.3) 8.5 (5.9) 10.4 (6.5)
Apathy Scale 10.7 (6.3) 9.9 (5.9) 11.6 (6.5)
State-Trait Anxiety Inventory-Trait Scale 35.4 (9.8) 34.0 (9.6) 37.0 (9.8)

UPDRS= Unified Parkinson’s Disease Rating Scale-Part III; SD= standard deviation; MCI= mild cognitive impairment